Riskpilot← Back to searchSign inGet full accessDermly AB
ABDissolvedOrg 5592085707Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2023
SEK 0
EBITDA margin
—
+95% vs 2022
Equity ratio
52.4%
Financial strength
Net profit 2023
SEK 0
+100% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -63K | +95% |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 105K | -55% |
| Equity | SEK 55K | +0% |
| Employees | 0 | — |
Legal name
Dermly AB
Org number
5592085707
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 juni 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva tjänster inom hälso- och sjukvård, utbildning, utveckling av plattform inom telemedicin samt uthyrning och försäljning av medicinsk utrustning. Bedriva handel med fastigheter, värdepapper, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 43 | 586 | 97 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −82 | −24 | −1 457 | −1 273 | −63 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −82 | −24 | −1 457 | −1 273 | −63 |
| Net financials | — | — | −5 | −4 | 6 |
| Profit before tax | −82 | −25 | 38 | −1 278 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −82 | −25 | 38 | −1 278 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 91 | 418 | 865 | 234 | 105 |
| Equity | 89 | 64 | 103 | 55 | 55 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 354 | 762 | 178 | 50 |
| Total debt | 1 | 354 | 762 | 178 | 50 |
EBITDA margin
-6300000.0%
This company
15.8%
Market median
-39873518% vs market
20192023
Equity ratio
52.4%
This company
38.2%
Market median
+37% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-06-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
LP Chief Auditor | Chief Auditor | 2021 | — | — |
PP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Docty AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medical Supply Sweden AB
Dermly AB Board members of Dermly AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Johan Ryrberg | Chief Executive Officer | 0 companies |
| Leif Patrik Adolfsson | Chief Auditor | 0 companies |
| Pontus Philip Kressner | Chief Executive Officer | 0 companies |
| Luke William Harvey Buhl-Nielsen | Chairman | 0 companies |
| Lars Peter Fredrik Hammarsten | Board of Directors | 0 companies |
| Åsa Anita Dahlgren | Deputy Board Member | 0 companies |
| Zinaida Bucharbajeva | Board of Directors | 0 companies |
| Sarah Victoria von Euler-Chelpin | Board of Directors | 0 companies |
| Monica Hansson | Board of Directors | 0 companies |
| Markus Bohlin | Chairman | 0 companies |
| Erik Gunnar Hjelmstedt | Chairman | 0 companies |
| Tor Kalle Conneryd Lundgren | Board of Directors | 0 companies |
| Tage Niklas Jansson | Chairman | 0 companies |
| Claes Mikael Ruth | Chairman | 0 companies |
| Daniel Marcus Lieb Nosek | Board of Directors | 0 companies |